Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions-Reference-Cited by-同舟云学术

Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

Published:2019-10-11 Issue:12 Volume:13 Page:2633-2645
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Villatoro Sergio¹^ORCID,Mayo‐de‐las‐Casas Clara¹,Jordana‐Ariza Núria¹,Viteri‐Ramírez Santiago²,Garzón‐Ibañez Mónica¹,Moya‐Horno Irene³,García‐Peláez Beatriz¹,González‐Cao María²,Malapelle Umberto⁴,Balada‐Bel Ariadna¹,Martínez‐Bueno Alejandro²,Campos Raquel¹,Reguart Noemí⁵,Majem Margarita⁶,Blanco Remei⁷,Blasco Ana⁸,Catalán María J.¹,González Xavier³,Troncone Giancarlo⁴,Karachaliou Niki¹⁹,Rosell Rafael¹²¹⁰,Molina‐Vila Miguel A.¹^ORCID

Affiliation:

1. Laboratory of Oncology Pangaea Oncology Quirón Dexeus University Hospital Barcelona Spain

2. Dr Rosell Oncology Institute Quirón Dexeus University Hospital Barcelona Spain

3. Dr Rosell Oncology Institute General Hospital of Catalonia Sant Cugat del Vallés Spain

4. Department of Public Health University of Naples Federico II Italy

5. Department of Medical Oncology Hospital Clínic Barcelona Spain

6. Medical Oncology Service Hospital de Sant Pau Barcelona Spain

7. Medical Oncology Service Hospital de Terrassa Spain

8. Medical Oncology Department Hospital General Universitario de Valencia Spain

9. Dr Rosell Oncology Institute University Hospital Sagrat Cor Barcelona Spain

10. Cancer Biology and Precision Medicine Program Catalan Institute of Oncology Germans Trias i Pujol Health Sciences Institute and Hospital Badalona Spain

Funder

Centre for Industrial Technological Development

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12574

Reference40 articles.

1. Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease

2. Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients

3. Successful Treatment with Gefitinib in Advanced Non–Small Cell Lung Cancer after Acquired Resistance to Osimertinib